GO:0030551 cyclic nucleotide binding: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0030551 (cyclic nucleotide binding) is a molecular function describing the binding of a protein to a cyclic nucleotide, in which the phosphate group forms a diester linkage to two positions on the sugar residue.
• Cyclic nucleotide binding domains are found in diverse protein families including cyclic nucleotide-gated channels, HCN channels, GAF-domain phosphodiesterases, and bacterial antiphage defence proteins [1,2,4].
• The cyclic nucleotide-binding membrane protein Csx23 mediates CRISPR antiphage defence, linking this molecular function directly to prokaryotic immunity.
• Cyclic dinucleotide binding by phospholipases drives filamentous assembly and broad CBASS immunity, showing that cyclic nucleotide binding extends beyond canonical cAMP/cGMP signalling.
• Altered cyclic nucleotide binding and pore opening in mutant HCN4 channels are associated with human cardiac disease, making this function clinically relevant.
• Cyclic nucleotide compartmentalization by phosphodiesterases and ATP-binding cassette transporters shapes local signalling specificity and is a major regulatory layer.
Description
Cyclic nucleotide binding (GO:0030551) is a molecular function defined as the binding to a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue. This function is central to signal transduction because cyclic nucleotides such as cAMP and cGMP serve as second messengers that are sensed by dedicated binding domains. Structural and mechanistic studies of cyclic nucleotide binding GAF domains from phosphodiesterases have revealed how these domains discriminate among cyclic nucleotides and translate binding into conformational change. Cyclic nucleotide-gated channels and cyclic nucleotide-regulated cation channels use related binding modules to couple ligand occupancy to ion flux, a process fundamental to sensory and pacemaker physiology [2,6]. Beyond canonical eukaryotic signalling, cyclic nucleotide binding has been identified in bacterial antiphage defence systems, where the cyclic nucleotide-binding membrane protein Csx23 contributes to CRISPR-mediated immunity. Cyclic dinucleotide-induced filamentous assembly of phospholipases further demonstrates that cyclic nucleotide binding governs broad CBASS immunity in bacteria. For researchers, GO:0030551 provides a precise annotation axis to interrogate ligand recognition, allosteric regulation, and disease-linked channel dysfunction. Understanding this function is therefore essential for pharmacology, channel physiology, and the engineering of CRISPR-associated defence modules.
cyclic nucleotide binding At A Glance
| GO ID | GO:0030551 |
|---|---|
| GO term | cyclic nucleotide binding |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding to a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue |
| Representative protein families | Cyclic nucleotide-gated channels, HCN channels, GAF-domain phosphodiesterases, Csx23, CBASS phospholipases |
| Related ligands | cAMP, cGMP, cyclic dinucleotides |
| Disease relevance | Cardiac channel dysfunction such as altered HCN4 pore opening |
| Research applications | Channel physiology, phosphodiesterase pharmacology, CRISPR antiphage defence, CBASS immunity |
What Is GO:0030551?
In our own words, GO:0030551 describes the ability of a protein or protein domain to selectively and non-covalently interact with a cyclic nucleotide. A cyclic nucleotide is a nucleotide whose phosphate group is connected through a diester linkage to two positions on the sugar ring, creating a cyclic structure. This definition is based on the QuickGO entry for GO:0030551 and is illustrated by structural studies of cyclic nucleotide binding GAF domains from phosphodiesterases.
Why Is cyclic nucleotide binding Important in Cell Biology?
Cyclic nucleotide binding is important because it converts the concentration of small cyclic nucleotide messengers into defined protein conformational changes that control ion flux, enzyme activity, and immune signalling [1,2,6]. Structural work on GAF domains has clarified how phosphodiesterases read cyclic nucleotide levels, which is directly relevant to drug discovery. In the nervous system and heart, cyclic nucleotide-gated and HCN channels rely on this binding function to regulate sensory transduction and pacemaker activity [2,6]. Disease-linked mutations in HCN4 alter cyclic nucleotide binding and pore opening, underscoring the clinical value of this annotation. In bacteria, cyclic nucleotide binding underlies CRISPR antiphage defence through Csx23 and CBASS immunity through phospholipase assembly, expanding the importance of GO:0030551 to microbiology and biotechnology [4,8].
• Provides the molecular basis for second-messenger sensing by cAMP and cGMP.
• Controls ion flux through cyclic nucleotide-gated and HCN channels in sensory and cardiac tissues [2,6].
• Regulates phosphodiesterase activity through GAF domains, influencing cyclic nucleotide compartmentalization [1,5].
• Is linked to human cardiac disease via altered HCN4 channel binding and pore opening.
• Underpins CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.
• Drives cyclic dinucleotide-induced filamentous assembly of phospholipases in CBASS immunity.
• Shapes local signalling specificity through phosphodiesterase and ATP-binding cassette transporter compartmentalization.
• Offers a target axis for pharmacological modulation of cyclic nucleotide signalling [1,5].
• Enables comparative analysis of ligand-binding domains across eukaryotes and prokaryotes [1,4].
• Supports structural and mechanistic studies of allostery in channel and enzyme families [1,7].
Molecular Mechanism of cyclic nucleotide binding
Ligand recognition by cyclic nucleotide binding domains
In simple terms: The protein has a pocket that fits a cyclic nucleotide like a key in a lock.
Cyclic nucleotide binding GAF domains from phosphodiesterases provide structural and mechanistic insights into how a binding pocket recognizes the cyclic phosphate linkage and discriminates among cyclic nucleotides. This recognition is the first step that converts ligand occupancy into a functional response.
Conformational coupling in cyclic nucleotide-gated channels
In simple terms: When the cyclic nucleotide docks, the channel changes shape and opens.
Cyclic nucleotide-gated channels and cyclic nucleotide-regulated cation channels couple ligand binding to pore opening, allowing ions to flow in response to cAMP or cGMP [2,6]. This coupling is essential for sensory transduction and pacemaker activity [2,6].
Disease-linked alterations in HCN4 binding and pore opening
In simple terms: A mutation can make the channel respond abnormally to cyclic nucleotides.
Altered cyclic nucleotide binding and pore opening have been described in a diseased human HCN4 channel, linking this molecular function to cardiac pathophysiology. Such findings help explain how mutations perturb channel gating.
Cyclic nucleotide binding in CRISPR antiphage defence
In simple terms: Bacteria use cyclic nucleotide binding proteins as part of their immune defence.
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23 demonstrates that this molecular function operates in prokaryotic immunity. This expands the functional repertoire of cyclic nucleotide binding beyond classical eukaryotic signalling.
Cyclic dinucleotide-induced assembly in CBASS immunity
In simple terms: Cyclic dinucleotides can make immune proteins assemble into filaments.
Cyclic-dinucleotide-induced filamentous assembly of phospholipases governs broad CBASS immunity, showing that cyclic nucleotide binding can trigger higher-order assembly. This mechanism links ligand binding directly to immune effector activation.
Compartmentalization and regulation of cyclic nucleotide signals
In simple terms: Cells keep cyclic nucleotide signals local by using enzymes and transporters.
Cyclic nucleotide compartmentalization is shaped by phosphodiesterases and ATP-binding cassette transporters, which control the local availability of ligands for binding proteins. This regulation ensures that cyclic nucleotide binding events are spatially and temporally specific.
Key Genes Involved in GO:0030551 cyclic nucleotide binding
The following genes and proteins represent major experimental entry points for studying cyclic nucleotide binding (GO:0030551).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDE2A | GAF-domain phosphodiesterase that binds cyclic nucleotides | Structural and mechanistic studies of cyclic nucleotide binding GAF domains |
| PDE5A | cGMP-binding phosphodiesterase | Cyclic nucleotide binding and compartmentalization [1,5] |
| PDE6 | Photoreceptor phosphodiesterase with GAF domains | Cyclic nucleotide binding in visual signalling |
| CNGA1 | Cyclic nucleotide-gated channel subunit | Cyclic nucleotide-gated channel physiology |
| CNGB1 | Cyclic nucleotide-gated channel subunit | Sensory transduction and channel regulation |
| HCN1 | Hyperpolarization-activated cyclic nucleotide-gated channel | Cyclic nucleotide-regulated cation channel function |
| HCN2 | Hyperpolarization-activated cyclic nucleotide-gated channel | Pacemaker current regulation |
| HCN4 | Hyperpolarization-activated cyclic nucleotide-gated channel | Disease-linked altered cyclic nucleotide binding and pore opening |
| Csx23 | Cyclic nucleotide-binding membrane protein | CRISPR antiphage defence |
| CBASS phospholipase | Cyclic dinucleotide-binding effector | Cyclic dinucleotide-induced filamentous assembly and immunity |
| STING | cGAS pathway component linked to autophagy induction | Cyclic dinucleotide signalling and autophagy |
| ABCC transporters | ATP-binding cassette transporters affecting cyclic nucleotide compartmentalization | Cyclic nucleotide compartmentalization |
| cGAS | Cyclic GMP-AMP synthase | Cyclic dinucleotide synthesis and STING trafficking |
| CNGA3 | Cyclic nucleotide-gated channel subunit | Cyclic nucleotide-gated channel function |
| CNGB3 | Cyclic nucleotide-gated channel subunit | Cyclic nucleotide-gated channel function |
| PDE10A | cAMP/cGMP phosphodiesterase | Cyclic nucleotide binding and signalling |
| PDE11A | cAMP/cGMP phosphodiesterase | Cyclic nucleotide binding and signalling |
How Is cyclic nucleotide binding Regulated?
Cyclic nucleotide binding is regulated by the local concentration of cyclic nucleotides, which is controlled by synthesis and degradation. Cyclic nucleotide compartmentalization is shaped by phosphodiesterases and ATP-binding cassette transporters, which restrict ligand availability to specific subcellular domains. In phosphodiesterases, GAF domains provide a structural mechanism for sensing cyclic nucleotide levels and coupling binding to catalytic regulation. In channels, cyclic nucleotide binding is coupled to pore opening, and disease-linked mutations can alter this coupling. In bacteria, cyclic dinucleotide binding triggers filamentous assembly of phospholipases during CBASS immunity, illustrating regulation by ligand-induced oligomerization.
cyclic nucleotide binding and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HCN4 | Cardiac channel dysfunction with altered cyclic nucleotide binding and pore opening | Point-mutation knock-in of disease-associated HCN4 variants |
| CNGA1 | Sensory transduction defects | Knockout and rescue in cyclic nucleotide-gated channel models |
| CNGB1 | Sensory transduction defects | Knockout and rescue in cyclic nucleotide-gated channel models |
| STING | Innate immunity and autophagy | Knockout to study cGAS-STING trafficking and autophagy |
| Csx23 | CRISPR antiphage defence | Knockout in bacterial defence assays |
Cardiac channel dysfunction and HCN4
Altered cyclic nucleotide binding and pore opening in a diseased human HCN4 channel link GO:0030551 to cardiac pathophysiology. This provides a direct example of how a mutation in a cyclic nucleotide binding protein can change channel gating.
Cyclic nucleotide signalling in sensory and neuronal systems
Cyclic nucleotide-gated channels and cyclic nucleotide-regulated cation channels are central to sensory transduction and neuronal excitability, so perturbations in cyclic nucleotide binding can affect these processes [2,6].
Innate immunity and cyclic dinucleotide signalling
Autophagy induction via STING trafficking is a primordial function of the cGAS pathway, connecting cyclic dinucleotide signalling to innate immunity. Cyclic dinucleotide-induced filamentous assembly of phospholipases further links cyclic nucleotide binding to CBASS immunity.
Bacterial defence and CRISPR systems
CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23 demonstrates that cyclic nucleotide binding participates in prokaryotic immunity. This has implications for understanding CRISPR-associated defence mechanisms.
From cyclic nucleotide binding-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a cyclic nucleotide binding protein alter channel function? | Knockout cell model |
| Does a disease-associated mutation change ligand binding or gating? | Point-mutation knock-in |
| Can a tagged cyclic nucleotide binding protein be tracked in live cells? | Tagged knock-in |
| Does overexpression of a cyclic nucleotide binding protein change signalling? | Overexpression cell model |
| Which genes modify cyclic nucleotide binding phenotypes? | CRISPR library screening |
| What pathways are enriched in cyclic nucleotide binding mutants? | Bioinformatics analysis |
How to Study the cyclic nucleotide binding Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Isothermal titration calorimetry | Ligand binding affinity | Cyclic nucleotide binding domain characterization |
| X-ray crystallography | Three-dimensional structure of ligand-bound domains | GAF domain structural studies |
| Patch-clamp electrophysiology | Ion channel opening in response to cyclic nucleotides | Cyclic nucleotide-gated channel function [2,6] |
| Site-directed mutagenesis | Effect of specific residues on binding and gating | HCN4 disease variant analysis |
| Bacterial antiphage assays | Defence against phage infection | Csx23 CRISPR defence studies |
| Filament assembly assays | Ligand-induced oligomerization | CBASS phospholipase immunity |
| CRISPR knockout screening | Gene requirement for cyclic nucleotide binding phenotypes | Functional genomics |
| Bioinformatics pathway analysis | Enriched pathways and networks | Interpretation of cyclic nucleotide binding datasets |
Structural and biochemical binding assays
Structural and mechanistic studies of cyclic nucleotide binding GAF domains from phosphodiesterases have used biochemical and structural approaches to define ligand recognition. These methods can be adapted to other cyclic nucleotide binding proteins.
Electrophysiology of cyclic nucleotide-gated channels
Cyclic nucleotide-gated channels and cyclic nucleotide-regulated cation channels are studied by electrophysiology to measure how binding controls pore opening [2,6]. This is essential for linking molecular function to ion flux [2,6].
Disease variant functional analysis
Altered cyclic nucleotide binding and pore opening in a diseased human HCN4 channel were characterized by functional analysis of the mutant channel. Similar workflows can test other disease-linked variants.
Bacterial defence and immunity assays
CRISPR antiphage defence mediated by Csx23 and cyclic dinucleotide-induced phospholipase assembly in CBASS immunity are studied using bacterial defence assays [4,8]. These assays connect cyclic nucleotide binding to organismal immunity [4,8].
How CRISPR Can Be Used to Study GO:0030551 cyclic nucleotide binding
Knockout
CRISPR knockout can remove a cyclic nucleotide binding protein to test whether it is required for channel function, phosphodiesterase regulation, or bacterial defence [1,4]. Knockout models are useful for establishing causality in cyclic nucleotide binding pathways [1,4].
Point Mutation
Point mutation knock-in can introduce disease-associated variants such as those in HCN4 to study altered cyclic nucleotide binding and pore opening. This approach directly tests the functional impact of specific residues.
Knock-in
Tagged knock-in allows endogenous cyclic nucleotide binding proteins to be tracked and purified without overexpression artifacts. This is valuable for studying localization and complex assembly.
Overexpression
Overexpression of cyclic nucleotide binding proteins can amplify signalling outputs and enable biochemical purification for structural studies [1,5]. It is also used to probe gain-of-function effects in cells [1,5].
How EDITGENE Supports cyclic nucleotide binding Research
Researchers studying cyclic nucleotide binding-related genes often need to determine whether a candidate gene is causally involved in ligand sensing, channel gating, or immune defence. EDITGENE provides CRISPR-based cell models and screening services to test these hypotheses rigorously.
Contact EDITGENE today to design your custom CRISPR model for cyclic nucleotide binding research.
Frequently Asked Questions About cyclic nucleotide binding
What is cyclic nucleotide binding?
Cyclic nucleotide binding (GO:0030551) is the binding to a cyclic nucleotide, a nucleotide in which the phosphate group is in diester linkage to two positions on the sugar residue.
What genes are involved in cyclic nucleotide binding?
Genes include PDE2A, PDE5A, PDE6, CNGA1, CNGB1, HCN1, HCN2, HCN4, Csx23, and CBASS phospholipases, among others [1,2,4,6,7,8].
What is the GO ID for cyclic nucleotide binding?
The GO ID is GO:0030551.
Which proteins contain cyclic nucleotide binding domains?
Cyclic nucleotide binding GAF domains from phosphodiesterases, cyclic nucleotide-gated channels, HCN channels, Csx23, and CBASS phospholipases contain such domains [1,2,4,6,8].
How is cyclic nucleotide binding studied?
It is studied by structural biology, biochemical binding assays, electrophysiology, and bacterial defence assays [1,2,4,6,7,8].
Why is cyclic nucleotide binding important in disease?
Altered cyclic nucleotide binding and pore opening in a diseased human HCN4 channel links this function to cardiac pathophysiology.
What is the role of cyclic nucleotide binding in CRISPR defence?
The cyclic nucleotide-binding membrane protein Csx23 mediates CRISPR antiphage defence.
How do cyclic dinucleotides relate to cyclic nucleotide binding?
Cyclic dinucleotide-induced filamentous assembly of phospholipases governs broad CBASS immunity.
What regulates cyclic nucleotide availability for binding?
Phosphodiesterases and ATP-binding cassette transporters contribute to cyclic nucleotide compartmentalization.
Can CRISPR be used to study cyclic nucleotide binding?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can test the function of cyclic nucleotide binding proteins [1,4,7].
Conclusion
GO:0030551 cyclic nucleotide binding is a fundamental molecular function that connects cyclic nucleotide messengers to protein conformational change, ion flux, enzyme regulation, and immune defence [1,2,4,6,8]. Its relevance spans cardiac disease, sensory physiology, and bacterial immunity, making it a rich target for mechanistic and translational research [3,4,7]. CRISPR-based models and screening approaches provide a direct route to test causality and identify modifiers of cyclic nucleotide binding pathways [1,4,7].
References
- 1. Heikaus CC et al.. 2009. Cyclic nucleotide binding GAF domains from phosphodiesterases: structural and mechanistic insights.. Structure 17(12):1551-1557 PMID: 20004158
- 2. Biel M et al.. 2009. Cyclic nucleotide-gated channels.. Handb Exp Pharmacol PMID: 19089328
- 3. Gui X et al.. 2019. Autophagy induction via STING trafficking is a primordial function of the cGAS pathway.. Nature 567(7747):262-266 PMID: 30842662
- 4. Grüschow S et al.. 2024. CRISPR antiphage defence mediated by the cyclic nucleotide-binding membrane protein Csx23.. Nucleic Acids Res 52(6):2761-2775 PMID: 38471818
- 5. Cheepala S et al.. 2013. Cyclic nucleotide compartmentalization: contributions of phosphodiesterases and ATP-binding cassette transporters.. Annu Rev Pharmacol Toxicol 53:231-53 PMID: 23072381
- 6. Biel M. 2009. Cyclic nucleotide-regulated cation channels.. J Biol Chem 284(14):9017-21 PMID: 19054768
- 7. Ng LCT et al.. 2022. Altered cyclic nucleotide binding and pore opening in a diseased human HCN4 channel.. Biophys J 121(7):1166-1183 PMID: 35219649
- 8. Wang J et al.. 2025. Cyclic-dinucleotide-induced filamentous assembly of phospholipases governs broad CBASS immunity.. Cell 188(14):3744-3756.e16 PMID: 40345202
